PERSPECTIVES

Our understanding of biology in human disease alongside innovation in biomedical science and digital solutions should allow us to bring therapies to patients sooner and at significantly lower cost. The time is right for a holistic, disruptive change to enable equitable access to high-quality medicines.

Bio

Dr. Carlos Garcia-Echeverria is an accomplished drug discovery scientist and executive, focused on bringing new therapies to patients in need.

Carlos has provided scientific leadership to drug discovery and early clinical development teams across different modalities and diseases most recently at Sanofi as Chief Operating Officer of Research and at Novartis as Executive Director, Oncology Drug Discovery Head. Carlos has also broad experience in managing research partnerships. His research accomplishments are documented by 190 peer-reviewed articles, book chapters and review papers, and 45 granted patents.

Carlos holds a PhD in organic chemistry from the University of Barcelona and received the Leonidas Zerwas Award from the European Peptide Society in recognition of his outstanding contributions to peptide science. Carlos is a member of the Scientific Advisory Board of several biotech companies.

View All